Our work suggests that APOE4 microglia have compromised microglial functions including diminished migratory capacity and heightened pro-inflammatory responses compared to APOE2, and these may underlie the increased risk of AD seen in carriers of this isoform. This evidence concerns the gene APOE and Alzheimer disease.